ETF · L&G
BIGT Pharma Breakthrough
ISIN IE00BF0H7608Legal & General Group Plc
- Healthcare
- ETF
- ISA
- SIPP
- Accumulating
Reference data only
We hold this instrument’s reference details (ISIN, name, type, currency). Prices, charges and returns are not available for it yet.
Past returns
- 1 year
- +9.0%
- +5.2% after inflation (UK CPIH)
- 3 years
- +40.9%
- +26.8% after inflation (UK CPIH)
- 5 years
- +15.3%
- −9.6% after inflation (UK CPIH)
£1,000 put in five years ago would have been worth about £1,153 — about £904 in today’s spending power, once price rises are taken out. Past performance is not a guide to future returns.
Volatility and the largest fall need a longer record of this fund’s prices than we hold so far. They appear on this page once we do.
Returns: as reported (delayed data). Inflation: UK CPIH, latest month published.
How we work it out:ReturnsReturns after inflationTotal returnReal returnCPIH
In plain English
Legal & General UCITS ETF Plc - Pharma Breakthrough is an exchange-traded fund (ETF) from L&G, launched in 2018.
It tracks the Solactive Pharma Breakthrough Value Index.
You buy and sell it through a share-dealing account or platform during stock-market hours, like a share.
Income from its investments is reinvested inside the fund, so it shows up as a rising price rather than cash paid to you.
Healthcare: Pharmaceutical, biotech and medical-equipment companies.
Terms:ETFIndex fundUCITSAccumulating or incomeShare classISIN
Key facts
- Ticker
- BIGT
- ISIN
- IE00BF0H7608
- Also listed as
- BIOT (London Stock Exchange, US dollars), ETLI (Xetra, euros)
- Provider
- L&G
- Tracks
- Solactive Pharma Breakthrough Value Index
- Structure
- ETF
- An exchange-traded fund: bought and sold on the stock exchange through the day, like a share.
- Income
- Accumulating
- Income is reinvested inside the fund, so it shows up as a rising price rather than cash paid to you.
- Fund size
- £18.1m
- Launched
- Domicile
- Ireland
- UK reporting fund status
- Yes — on HMRC’s list of reporting funds (list of )
- Reporting fund since . What reporting fund status means
- Can usually be held in
- ISA and SIPP
- Check with your platform: each decides which funds it offers.
- Currency hedged
- No
- Category
- Healthcare
Questions people ask
What does BIGT track?
BIGT tracks the Solactive Pharma Breakthrough Value Index.
Is BIGT accumulating or distributing?
BIGT is accumulating: income is reinvested inside the fund, so it shows up as a rising price rather than cash paid to you.
What is the ISIN of BIGT?
The ISIN of BIGT is IE00BF0H7608. An ISIN identifies one exact share class of a fund; BIGT is its ticker on the London Stock Exchange. The same share class is also listed as BIOT (London Stock Exchange, US dollars) and ETLI (Xetra, euros).
Similar funds
- XWHSXtrackers MSCI World Health Care UCITS ETF0.25% a year · £3.4bn
- IHCUiShares S&P 500 Health Care Sector UCITS ETF0.15% a year · £2.7bn
- DRDRiShares Healthcare Innovation UCITS ETF0.40% a year · £1.2bn
- XSHCXtrackers MSCI USA Health Care UCITS ETF0.12% a year · £1.2bn
- BTEKiShares NASDAQ US Biotechnology UCITS ETF0.35% a year · £994m
- CH5Amundi STOXX Europe 600 Healthcare UCITS ETF -Acc- Capitalisation0.30% a year · £847m
- ESIHiShares MSCI Europe Health Care Sector UCITS ETF Accum EUR0.18% a year · £792m
- 0DW6Amundi MSCI World Health Care UCITS ETF EUR ACC0.30% a year · £779m
Fund documents and methods
- Fund documents
- Fund page at L&G (links checked )
Methodology:ReturnsCategoriesAll methods
A machine-readable copy of this page: Markdown.